CS Paper Radar

Longitudinal retinal imaging and auxiliary tasks for discrete-time survival prediction of referable diabetic retinopathy and maculopathy: a retrospective cohort study

Paul Nderitu, Laura Webster, Samantha S. Mann, Christos Bergeles, Timothy L. Jackson

eess.IV ·submitted 2026-10-27 16:56 UTC · v1

Abstract

Deep learning can predict progression to referable diabetic retinopathy (rDR) and referable maculopathy (rM) from screening photographs, but existing models ignore the prior images that screening programmes hold. We assessed whether multi-visit (MV) images and auxiliary objectives that model the future visit improve prognostic prediction. In this retrospective cohort study of macula-centred photographs from the South-East London Diabetic Eye Screening Programme (UK), eyes without referable disease at baseline and with a follow-up at 20-28 months were split into development (72,559 eyes, 36,648 patients) and test (17,917 eyes, 9,071 patients) sets. A time-aware discrete-time survival model predicted incident rDR (R2 or R3), rM (M1), or either (rDR/rM). We compared baseline-only input with up to three visits (MV), alone or with auxiliary supervision of future-visit age (MV+age) or future-visit latent prediction (MV+latent), using the AUROC of 28-month cumulative risk and paired DeLong tests with Benjamini-Hochberg correction. In the test set, 308 eyes (1.7%) developed rDR/rM, 58 (0.3%) rDR, and 275 (1.5%) rM. MV images increased the AUROC for rDR/rM from 0.749 to 0.786 (+0.037, 95% CI 0.012-0.061; q=0.011) and for rM from 0.749 to 0.788 (+0.039, 0.013-0.065; q=0.010). Auxiliary objectives did not improve MV model performance. In eyes with two or three visits, prior visits accounted for 30-38% of positive Grad-CAM attributions. Prior screening images improved prediction of incident maculopathy and the composite rDR/rM outcome, with gains driven by longitudinal images, not auxiliary supervision. External validation and prospective studies are required before the deployment of models to individualise screening.

Closest papers

Nearest neighbours by meaning across the whole index.

A Disease-specific Retinal Aging Biomarker for Predicting Progression to Late Age-related Macular Degeneration

cs.CV ·2026-11-12 ·Hexin Dong, Benjamin Hou, Puzhen Wu, Mingquan Lin, Emily Y. Chew +2 more
similarity 0.66
Abstract · 41 pages, 13 figures (including supplementary material)

Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss in older adults. While chronological age is a primary risk factor, it inadequately reflects individual variations in retinal aging, limiting effective AMD risk stratification and timely intervention. Here, we propose and validate fundus-based AMD age (FAA), which quantifies disease-specific retinal aging in AMD and captures accelerated AMD-related retinal aging, thereby improving prognostic precision over chronological age. Trained on 36,782 images from 2,192 participants in the Age-Related Eye Disease Study (AREDS) dataset and validated across AREDS and AREDS2 cohorts, our model demonstrates significant improvements over traditional chronological age-based approaches. Specifically, integrating the proposed FAA into Cox proportional-hazards models significantly enhances prediction performance. FAA improved the C-index from 0.836 to 0.888 and reduced the 5-year Brier score from 0.050 to 0.046 in AREDS, with consistent gains observed in AREDS2 (C-index 0.715 to 0.756; 2-year Brier 0.078 to 0.076). FAA showed improved prognostic performance across the two datasets and under different phenotype definitions (reading center-defined vs. specialist-defined grading), supporting its potential utility for AMD risk stratification. These findings highlight the advantage of incorporating FAA into AMD risk prediction frameworks, supporting further evaluation of FAA for AMD risk stratification.

0.21

Self-supervised Pre-training Helps Retinal Disease Progression Modelling Most When Data Is Scarce

cs.CV ·2026-09-11 ·Ifeoma Veronica Nwabufo, Julius Gervelmeyer, Sarah Müller, Philipp Berens
similarity 0.66
Abstract

Modelling how a disease progresses over time requires longitudinal imaging cohorts, which are scarce and small, whereas cross-sectional data -- one image per participant -- is abundant. Self-supervised pre-training on such data offers a way to bridge this gap, but it is unclear which strategy best supports progression modelling, or how that answer depends on the amount of labelled longitudinal data. We study this for age-related macular degeneration (AMD), pre-training encoders on the large cross-sectional NAKO cohort and predicting time to late AMD on the longitudinal AREDS dataset. We compare in-house self-supervised encoders against a general-purpose (DINOv2) and a domain-specific (RETFound) foundation model, across contrastive, masked-autoencoding, and self-distillation objectives, under frozen and fine-tuned protocols, and across labelled training sets from 100 to 32,250 examples. Which model performs best depends on how the encoder is used. When the encoder is frozen and labels are few -- the regime typical of longitudinal cohorts -- pre-trained representations reach clinically reasonable discrimination from a few hundred labelled samples, while models trained from scratch do not; this advantage fades under fine-tuning. Transfer is governed by the self-supervision objective rather than corpus scale or domain match, so that an encoder pre-trained on a modest cross-sectional cohort matches or exceeds a far larger in-domain foundation model. Together, these results offer a practical recipe for building progression models where longitudinal data is scarce: a frozen self-supervised encoder with a lightweight survival head.

0.15

Lesion-Aware Explainable AI for Diabetic Retinopathy Grading from Fundus Images

cs.CV cs.AI ·2026-11-14 ·Truong Thinh Nguyen, Hai Phong Nguyen, Truong Thanh Hung Nguyen, Giang Son Tran, Hung Cao
similarity 0.65
Abstract · 12 pages, 6 figures, 9 tables. Truong Thinh Nguyen and Hai Phong Nguyen contributed equally. Corresponding author: Truong Thinh Nguyen

Post-hoc explanations of deep-learning models for diabetic retinopathy (DR) grading are difficult to trust because different attribution methods highlight different retinal regions for the same image, and a visually plausible heatmap does not show that the highlighted pixels drive the prediction. We propose the Consensus-Calibrated Explanation Map (CCEM), which fuses Grad-CAM++, Ada-SISE, and SmoothGrad Integrated Gradients (SG-IG) using image-specific weights derived from annotation-free reliability cues: deletion sensitivity, inter-method agreement, compactness, retinal containment, and peak structure. CCEM explains a frozen ordinal grader, an EfficientNet-B7 with CBAM and a scalar regression head, pre-trained on EyePACS 2015 in Stage 1 and fine-tuned on APTOS 2019 in Stage 2 with quadratic weighted kappa (QWK)-optimized thresholds; it reaches a QWK of 0.920 on the hidden Kaggle test set and 0.559 on the external MAPLES-DR cohort. Explanations are evaluated on MAPLES-DR, 198 MESSIDOR images with expert pixel-level lesion annotations that are never used for training, threshold fitting, or fusion. On the 193 images with annotated lesions, CCEM obtains the highest Soft Pointing Game score (69.61%; 95% CI 63.7-75.3), defined as the ratio of the strongest lesion-supported saliency to the global map maximum rather than a lesion detection rate, together with the lowest deletion AUC (0.570) and the best deletion-insertion balance (0.115); each gain is significant against the strongest single explainer on paired tests. Annotation-free, per-image reliability weighting therefore turns three disagreeing explainers into one map whose peak evidence is more lesion-supported and more faithful to the model than that of any single explainer.

0.13

Exploring the Latent Structure of AMD Severity Using Retinal Foundation Models

eess.IV cs.CV ·2026-10-09 ·Niccolò Fineschi, Jovana Panic, Atsushi Watanabe, Hideaki Hayashi, Kazuya Nishimura +5 more
published similarity 0.65
Abstract · 7 pages, 5 figures. Accepted for publication at IEEE EMBS BHI 2026

Retinal foundation models have demonstrated strong performance across a wide range of ophthalmic tasks, yet relatively little is known about how disease-related information is represented within their learned embeddings and whether this distribution influences downstream prediction performance. In this work, we use Age-related Macular Degeneration (AMD) as a case study to investigate how disease severity is represented within the embedding space of RET-CLIP, a retinal vision-language foundation model, using bilateral fundus images from the AREDS dataset, benchmarked against non-retinal encoders. We first characterize the distribution of AMD severity within the learned representation space and then evaluate how this structure influences classification performance across three clinically relevant task formulations of increasing granularity. Finally, we analyze the most influential latent dimensions combining feature attribution, statistical phenotype association, and qualitative image analyses. Our results show that RET-CLIP represents AMD severity as a continuous spectrum rather than a set of discrete categories, with healthy and advanced disease stages exhibiting clearer separation than intermediate ones. This organization was reflected in downstream performance, which decreased from a balanced accuracy of 0.844 and 0.814 for binary AMD and Late-AMD detection respectively to 0.446 for six-class grading. Furthermore, the most influential latent dimensions were statistically associated to distinct retinal phenotypes, including drusen accumulation, pigmentary alterations, and advanced retinal lesions. These findings suggest that the structure of retinal foundation-model representations influences the difficulty of clinically relevant prediction tasks and demonstrate the potential of representation-level analysis for understanding disease organization and improving interpretability.

0.18

CF-NODE: Counterfactual Spatial Node Intervention for Test-Time Adaptation Under Domain Shift, Evaluated Across Five Diabetic Retinopathy Datasets

cs.LG cs.CV ·2026-10-15 ·Sabarish G, Deepak Parashar
similarity 0.64
Abstract

Automated fundus-based diabetic retinopathy (DR) grading can substantially expand screening capacity, but source-trained models degrade sharply across different cameras, clinics, and patient populations. Existing test-time adaptation methods depend on entropy minimization or target information accumulated from image batches and streams. These mechanisms can reinforce confidently incorrect predictions and break down when clinical images arrive independently. We introduce CF-NODE, a novel counterfactual test-time adaptation framework for cross- domain DR grading. Instead of trusting prediction confidence or estimating a target distribution, CF-NODE asks how each prediction responds under a controlled intervention on the evidence supporting it. CF-NODE ranks internal spatial nodes using model-derived attention, feature magnitude, and node-set similarity, progressively attenuates the highest-ranked nodes, and uses the stability of the resulting expected-grade response to apply a bounded calibration of the predicted grade distribution. The framework is fully frozen and adapts every image independently using only geometric views and a fixed source-derived prior, requiring no target-derived information or model updates. We evaluate CF-NODE on five external DR datasets under repeated-seed evaluation against TENT, EATA, SAR, and T3A. CF-NODE outperforms all four methods with statistically significant improvements over the second-best method, improves AUC on every target domain, and attains the highest average AUC and macro-F1, delivering stronger grade discrimination together with more balanced recognition across DR severity levels. These results demonstrate that counterfactual intervention sensitivity provides consistent and deployment-ready domain robustness for single-image clinical inference.

0.21

FOCUS: Benchmarking Retinal Model Generalization from Foundation Vision Encoders to Multimodal LLMs

cs.CV cs.AI ·2026-09-27 ·David Restrepo, Chenwei Wu, Luis Filipe Nakayama, Miguel L. Martins, Stergios Christodoulidis +2 more
top venuebenchmarkdatasetcode/data similarity 0.64
Abstract · Accepted at NeurIPS 2026, Evaluations & Datasets Track. Interactive benchmark dashboard: https://huggingface.co/spaces/dsrestrepo/FOCUS-Reti…

Progress in AI-based retinal image analysis has accelerated with the adoption of foundation models, yet evaluating their real-world reliability remains challenging. Performance reported on a single dataset does not capture how models behave under dataset shift, across clinical definitions, or for different patient subgroups. This limitation is particularly critical in medical imaging, where robustness, calibration, and fairness are essential for safe deployment. We introduce FOCUS (Foundation Ophthalmic Cross-Dataset Understanding under Shift), a cross-dataset benchmark evaluating retinal fundus models across vision-only encoder models (VM), vision-language dual-encoder models (VLM), and multimodal large language models (MLLM). FOCUS harmonizes binary diabetic retinopathy, referable diabetic retinopathy, and glaucomatous optic neuropathy tasks across ten public datasets spanning diverse geographies, acquisition conditions, and label protocols. The benchmark evaluates models through a unified analysis layer that measures ranking performance, calibration, subgroup disparities, and image-quality robustness. We present a large-scale evaluation covering 532 base configurations and 228 MLLM configurations adapted via LoRA fine-tuning. Results show no model family consistently dominates across tasks and datasets: general VM encoders achieve the strongest average ranking performance, medical MLLMs are competitive but variable, and dual-encoder VLMs benefit substantially from lightweight adaptation. Fine-tuning improves in-domain performance but exhibits heterogeneous transfer to external datasets, particularly in calibration. FOCUS provides a practical framework and public benchmark to assess generalization, reliability, and robustness beyond single-dataset leaderboards.

0.52

Beyond Accuracy: Benchmarking Uncertainty Quantification in Retinal Disease Screening

eess.IV ·2026-11-17 ·Mahvash Jebeli, Mohammad Eslami, Nazlee Zebardast, Lucia Sobrin, Tobias Elze
benchmarkdataset similarity 0.61
Abstract

Reliable uncertainty quantification (UQ) is essential for evaluating retinal AI systems beyond classification accuracy, yet it remains unclear whether existing UQ strategies generalize across diseases, model architectures, and reliability criteria. We introduce a large-scale, multi-disease benchmark comprising over $242,000$ fundus photographs from $32$ datasets covering diabetic retinopathy, age-related macular degeneration, and glaucoma. We evaluate six representative UQ strategies across three Vision Transformer configurations, assessing discrimination, probabilistic calibration, selective prediction, and conformal prediction-set coverage. Our findings reveal no universally superior model or UQ strategy: methods that improve reliability in one disease or architecture may underperform in another, while improvements in discrimination, calibration, and selective prediction do not necessarily align. Notably, computationally intensive methods do not consistently outperform simple confidence scores, and domain-specific foundation models and calibration-oriented loss functions do not guarantee greater reliability. In contrast, conformal prediction provides a complementary framework for achieving near-nominal marginal prediction-set coverage across diverse settings, subject to its statistical assumptions. These findings challenge universal UQ recommendations and highlight the need for disease-specific, model-specific, and multidimensional reliability evaluation before clinical deployment. We release standardized dataset splits, trained checkpoints, evaluation code, and an interactive research demonstration to support reproducible benchmarking.

0.06

From Canon to Nikon: Camera Domain Shift and Potential Equity Implications in Retinal AI

cs.CV cs.CY ·2026-10-21 ·Lisa Y. W. Tang
similarity 0.61
Abstract

Diabetic retinopathy is a leading cause of preventable blindness, yet access to regular screening remains limited worldwide. AI offers a scalable approach, but its performance can be sensitive to image quality and acquisition conditions. In a Brazilian cohort of 8,524 patients, retinal images acquired with the Nikon NF5050 were more than twice as likely to have inadequate image quality compared with those acquired with the Canon CR-2, despite refurbished Canon systems costing more than twice as much as Nikon systems. This potential cost-quality trade-off highlights an important consideration for the reliability of AI systems deployed across heterogeneous imaging systems. Using a frozen pretrained retinal foundation model, we systematically evaluate whether camera-associated performance differences persist across 12 retinal disease classification tasks, four input resolutions, and five downstream classifiers. We find that camera-associated performance differences vary substantially across tasks, and that neither higher input resolution nor classifier choice consistently mitigates cross-camera variation. These findings identify camera platform as a potentially overlooked source of performance variability, with implications for the safety and reliability of retinal AI when deployed across heterogeneous imaging systems. We release all source code, evaluation scripts, and per-task results on GitHub to support reproducible benchmarking.

0.24